These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 14266366)
1. [RESULTS OF THERAPY WITH EPSILON AMINOCAPROIC ACID (EACA) IN 2 CASES OF REFRACTORY PURPURA]. LAUGIER P; RISOLD JC Bull Soc Fr Dermatol Syphiligr; 1964; 71():647-8. PubMed ID: 14266366 [No Abstract] [Full Text] [Related]
2. [SEVERE HEMORRHAGIC PURPURA IN AN 89-YEAR-OLD MAN. SPECTACULAR CURE BY INTRAVENOUS INJECTIONS OF EPSILON-AMINOCAPROIC ACID]. FIEHRER A Rev Pathol Gen Physiol Clin; 1963 Jul; 63():773-7. PubMed ID: 14090125 [No Abstract] [Full Text] [Related]
3. THROMBOCYTOPENIA AFTER RUBELLA (REPORT OF TWO CASES). SVENNINGSEN NW Acta Paediatr Scand; 1965 Jan; 54():97-100. PubMed ID: 14248230 [No Abstract] [Full Text] [Related]
4. [PRELIMINARY OBSERVATIONS ON THE THERAPEUTIC EFFICACY OF EPSILON-AMINO-CAPROIC ACID IN HEMORRHAGIC SYNDROMES DUE TO BLOOD PLATELET DEFECTS]. MANDELLI F; DERIU L; OMODEI-ZORINI C Policlinico Prat; 1964 Sep; 71():1454-7. PubMed ID: 14204185 [No Abstract] [Full Text] [Related]
5. [HEMORRHAGIC DIATHESIS AND THE PHENOMENON OF FIBRINOLYSIS, WITH SPECIAL REFERENCE TO ITS INHIBITION]. SHIMIZU M; HAYASHI H Chiryo; 1964; 46():879-86. PubMed ID: 14144012 [No Abstract] [Full Text] [Related]
6. [PRESENT TRENDS IN THE THERAPY OF HYPERFIBRINOLYTIC STATES]. DETTORI AG; PONARI O Clin Ter; 1963 Oct; 27():97-114. PubMed ID: 14100829 [No Abstract] [Full Text] [Related]
7. [THE USE OF EPSILON-AMINOCAPROIC ACID IN PROSTATE SURGERY]. LASSNER J Anaesthesist; 1965 Feb; 14():33-4. PubMed ID: 14258321 [No Abstract] [Full Text] [Related]
9. [RECENT INFORMATION ON THE THERAPY OF BLOOD DISEASES]. HASEGAWA Y; TSUKADA R Chiryo; 1964; 46():501-9. PubMed ID: 14126913 [No Abstract] [Full Text] [Related]
10. ANTIFIBRINOLYTIC TREATMENT WITH EPSILON-AMINOCAPROIC ACID IN CONNECTION WITH PROSTATECTOMY. ANDERSSON L Acta Chir Scand; 1964 May; 127():552-64. PubMed ID: 14169785 [No Abstract] [Full Text] [Related]
11. THE USE OF THE SERIAL THROMBIN TIME IN EVALUATING THERAPY WITH EPSILON AMINOCAPROIC ACID IN MASSIVE THROMBOLYSIS AND PROTEOLYSIS. BRODSKY I; ROSS E; REID WO Am J Clin Pathol; 1964 Jun; 41():589-96. PubMed ID: 14183048 [No Abstract] [Full Text] [Related]
12. [THROMBOPENIC THROMBOTIC PURPURA: MOSCHOWITZ DISEASE. PRESENTATION OF AN ANATOMO-CLINICAL CASE AND REVIEW OF THE LITERATURE]. PEDROPONS A; SANS SABRAFEN J; ROZMAN C; RIBASMUNDO M; CISCAR F Prensa Med Argent; 1964; Suppl.():SUPPL:178-85. PubMed ID: 14222038 [No Abstract] [Full Text] [Related]
13. Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases. MacKay AR; Sang U H; Weinstein PR J Neurosurg; 1978 Oct; 49(4):597-601. PubMed ID: 690689 [TBL] [Abstract][Full Text] [Related]
14. Effect of probenecid on the kinetics of epsilon-aminocaproic acid. Dvorchik BH; Katlic KL; Hayes AH; Eyster ME Clin Pharmacol Ther; 1980 Aug; 28(2):223-8. PubMed ID: 7398189 [TBL] [Abstract][Full Text] [Related]